e-Edition
Obituaries
Photo Gallery
Magazines
News Crew
Paywall Login
Login to Comment
Register
December 15th, 2015
Menu
Home
News
Sports
Business
Entertainment
Federal Election
Classifieds
Life
Commentary
Contact
Local News
Provincial News
National News
World News
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Biogen, Inc.
(NQ:
BIIB
)
273.84
USD
-2.00 (-0.73%)
Streaming Delayed Price
Updated: 4:02 PM EST, Jan 19, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Blog posts about Biogen, Inc.
< Previous
1
2
3
4
5
Next >
Stock Update: Biogen Idec Inc. (NASDAQ:BIIB) – December 27th Options Now Available For Biogen Idec (BIIB)
November 21, 2013
[at Forbes] – Investors in Biogen Idec Inc (NASD: BIIB) saw new options begin trading today, for the December 27th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ....
Tags
Shares
NASDAQ:BIIB
Healthcare
From
Jutia Group
Biogen Idec Inc. (NASDAQ:BIIB) – Repligen Appoints Biogen Idec Executive John G. Cox to Board of Directors
November 19, 2013
[at noodls] – WALTHAM, Mass., Nov. 19, 2013 (GLOBE NEWSWIRE) — Repligen Corporation today announced that it has elected to its Board of Directors John G. Cox, Executive Vice President of Pharmaceutical...
Tags
Markets
Industry
Healthcare
From
Jutia Group
Biogen Idec Inc. (NASDAQ:BIIB) | Better Buy: Biogen or Amgen?
November 14, 2013
[at Motley Fool] – Both Biogen and Amgen are fighting competition with new drugs with blockbuster potential, but is one a better buy than the other? Read more on this. Biogen Idec . . . → Read More:...
Tags
Shares
NASDAQ:BIIB
Healthcare
From
Jutia Group
Company Update: Biogen Idec Inc. (NASDAQ:BIIB) – Leading Hematology Journal Publishes Pivotal ELOCTATE™ Data that Demonstrated Efficacy and Safety of Investigational Long-Lasting Therapy for Hemophili
November 13, 2013
[Business Wire] – Today Biogen Idec and Swedish Orphan Biovitrum AB announced that the detailed phase 3 data for the companies’ investigational long-lasting recombinant factor VIII Fc fusion protein...
Tags
Industry
Business
NASDAQ:BIIB
From
Jutia Group
What Traders Love So Much About This Sector
November 10, 2013
When we looked at Biogen Idec Inc. (BIIB) in late April, the biotechnology company was trading around $218.00 a share. Now, it’s trading between $230.00 and $240.00 or so and is still a big . . . →...
Tags
Business
Markets
Market Updates
From
Jutia Group
McDonalds Corporation (NYSE:MCD) | McDonald’s October Sales Rise as New Items Draw Diners
November 08, 2013
[at Bloomberg] – McDonald’s Corp., the world’s largest restaurant chain, said sales at stores open at least 13 months rose 0.5 percent in October, topping analysts’ estimates, as new items boosted...
Tags
Industry
Services
World
From
Jutia Group
Company Update: Mondelez International Inc (NASDAQ:MDLZ) – In-Line Earnings at Mondelez; Sales View Cut
November 07, 2013
[Zacks] – Mondelez reported dismal third-quarter 2013 results, managing to meet the Zacks Consensus Estimate for earnings but missing the same for revenues due to weak performance in China. Read more...
Tags
Shares
NASDAQ:MDLZ
Consumer Goods
From
Jutia Group
Time Warner Inc. (NYSE:TWX) ~ Time Warner Earnings Beat Estimate
November 06, 2013
[Zacks] – Time Warner posted third-quarter 2013 earnings of $1.01 per share that surpassed the Zacks Consensus Estimate of 89 cents and surged approximately 20% from 84 cents earned in the prior-year...
Tags
Industry
Services
Shares
From
Jutia Group
Market Update on General Motors Company (NYSE:GM) – U.S. October auto sales expected to show 12 percent rise
October 31, 2013
[Reuters] – U.S. auto sales to be reported on Friday are expected to be up 12 percent from a year ago as the federal government shutdown did not greatly impact consumer purchases. Analysts . . . → Read...
Tags
NYSE:GM
Markets
Government
From
Jutia Group
In Studies of Medtronic Stents, Patients Who Interrupted Dual Antiplatelet Therapy Early Saw No Increased Thrombosis Risk – Medtronic Inc. (NYSE:MDT)
October 31, 2013
[Thomson Reuters ONE] – New Data Presented at TCT and Published by JAMA Affirms Excellent Safety Profile of Zotarolimus-Eluting Stents SAN FRANCISCO — Oct. 31, 2013 — According to findings from several...
Tags
NYSE:MDT
Stock News
From
Jutia Group
Company Update: Biogen Idec Inc. (NASDAQ:BIIB) – BIIB December 6th Options Begin Trading
October 31, 2013
[at Forbes] – Investors in Biogen Idec Inc (NASD: BIIB) saw new options become available today, for the December 6th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down...
Tags
Stock News
Markets
NASDAQ:BIIB
From
Jutia Group
Why Tomorrow’s ExxonMobil Earnings Could Move the Dow – Exxon Mobil Corporation (NYSE:XOM)
October 30, 2013
[at Motley Fool] – Dow component Exxon Mobil reports its earnings tomorrow, and it could have a big impact not just on big oil peer Chevron, but also on General Electric and the . . . → Read More: Why...
Tags
NYSE:XOM
Stock News
income
From
Jutia Group
Stock Update: E. I. du Pont de Nemours and Company (NYSE:DD) – We Put These Chemical Earnings Under the Microscope
October 30, 2013
[at Motley Fool] – Several chemical companies, like DuPont, Ecolab, Huntsman and LyondellBasell, reported earnings recently. What, if anything, did they share in common? Read more on this. E. I. du...
Tags
Stock News
NYSE:DD
From
Jutia Group
We Put These Chemical Earnings Under the Microscope – LyondellBasell Industries N.V. (NYSE:LYB)
October 30, 2013
[at Motley Fool] – Several chemical companies, like DuPont, Ecolab, Huntsman and LyondellBasell, reported earnings recently. What, if anything, did they share in common? Read more on this....
Tags
Stock News
Oil
NYSE:LYB
From
Jutia Group
GM 3Q earnings fall, but beat Street forecasts – General Motors Company (NYSE:GM)
October 30, 2013
[AP] – General Motors’ third-quarter net income fell 53 percent compared with a year ago, as one-time expenses masked a strong performance in North America and a narrowed loss in Europe. The company ....
Tags
Markets
NYSE:GM
Stock News
From
Jutia Group
Company Update: Biogen Idec Inc. (NASDAQ:BIIB) – Multiple Of 40x Earnings Gives Biogen Idec The Wobblies
October 29, 2013
[at Seeking Alpha] – Would you be happy if your company reported a 32% increase in revenues, a 44% increase in profit (both above analyst estimates) and guided full year sales growth to . . . → Read...
Tags
NASDAQ:BIIB
Markets
Stock News
From
Jutia Group
Market Update on Biogen Idec Inc. (NASDAQ:BIIB) – Biogen’s new MS drug tops sales expectations, earnings rise
October 28, 2013
[Reuters] – Biogen Idec on Monday reported $286 million in third-quarter sales of its high-profile new multiple sclerosis drug Tecfidera, providing fresh evidence that the medicine is off to an...
Tags
Stock News
Markets
NASDAQ:BIIB
From
Jutia Group
Biogen Idec Inc. (NASDAQ:BIIB) – [video] Earnings Squad: BIIB, AAPL & STX
October 25, 2013
[at CNBC] – What to watch for in the earnings data of Biogen, Apple and Seagate on Monday, with CNBC’s Melissa Lee, Jackie DeAngelis and Dominic Chu. Read more on this. Biogen Idec . . . → Read More:...
Tags
NASDAQ:BIIB
Markets
Stock News
From
Jutia Group
Earnings for Biogen Projected to Rise – Biogen Idec Inc. (NASDAQ:BIIB)
October 24, 2013
[at Forbes] – Wall Street is expecting higher profit for Biogenwhen the company reports its third quarter results on Monday, October 28, 2013. The consensus estimate is calling for profit of $2.14 a ....
Tags
NASDAQ:BIIB
Stock News
Markets
From
Jutia Group
Stocks to Watch for October 21, 2013
October 19, 2013
Tags
P
VRNG
CCO
From
AC Investor Blog
Stock Market Today Reacts to Merger Monday on Wall Street
May 20, 2013
It was a muted start for U.S. equities when the stock market today (Monday) opened. But by mid-day, the bulls were back and benchmarks marched higher. Just before noon, the Dow Jones Industrial Average...
Tags
stock market trend
Dow Jones Industrial Average
stock market news
From
Money Morning
Best Investments: The One Stock to Buy in the Red-Hot Biotech Sector
April 09, 2013
For the best investments to add a little high-potential punch to your portfolio, nothing's better than biotech. The iShares Nasdaq Biotechnology Exchange Traded Fund (ETF) (Nasdaq: IBB ) rose 30.2% in...
Tags
best investments
best investments 2013
best investments now
From
Money Morning
Six Biotech Stocks Riding the Baby Boomer Wave
June 06, 2012
The size and scope of the Baby Boom generation has opened up an abundance of health care opportunities --especially ground-breaking and game-changing biotech stocks. As this "gray wave" matures the...
Tags
biotech investments
biotech stocks to watch
biotech stocks 2011
From
Money Morning
Biotech Stock ETFs: How to Ride the Surge in Biotech Mergers & Acquisitions
May 15, 2012
Tags: biotech diagnosis stocks, biotech news, biotech penny stocks, biotech stock market, biotech stocks, biotech stocks awaiting fda approval, biotech stocks list, biotech stocks to buy, biotech...
Tags
biotech stocks awaiting fda approval
trade biotech stocks
investing in biotechnology companies
From
Money Morning
Traders Storm Netflix Weeklies As Shares Continue To Tank
September 29, 2011
Today’s tickers: NFLX, BIIB, DG & DWA NFLX - Netflix, Inc. – The bloodbath at Netflix accelerated Thursday afternoon, with shares in the provider of subscription streaming service down 13.0% at...
Tags
BIIB
Uncategorized
NFLX
From
Phil's Stock World
Stock Watch List For Friday, Set 02
September 01, 2011
Tags
JAZZ
EGO
BIIB
From
AC Investor Blog
Another Immune Company Play – Immunomedics
February 13, 2011
Cancer is a class of diseases in which a group of cells display uncontrolled growth. Some cancers invade or intrude upon adjacent tissues, then destroy that tissue/organ, and then spread (metastasize)...
Tags
IMGN
IMMU
Members Only
From
Phil's Stock World
Stock Market Ideas for Friday, January 21
January 20, 2011
Tags
RMBS
BIIB
MS
From
AC Investor Blog
Bull of the Day: Biogen Idec (BIIB)
November 10, 2010
Biogen Idec (BIIB) reported third-quarter earnings of $1.33 per share, well above the year-ago figure of $1.20 and the Zacks Consensus Estimate of $1.09. Revenue increased 5% to $1.2 billion, with MS...
Tags
WallStreet
Business
Latest
From
Wall Street Pit
Biogen Idec: Earnings Preview
October 25, 2010
Biogen Idec Inc. (BIIB) is slated to announce its third quarter results on October 26. The Zacks Consensus Estimate is $1.20, well above the year-earlier earnings of $1.09. Second Quarter Highlights...
Tags
Business
WallStreet
Latest
From
Wall Street Pit
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.